NHS pharmacy chain owed £40m before it was bought out of administration February 8, 2024 An estimated £40m was owed by NHS pharmacy chain Medipharmacy before it collapsed into administration and was rescued, it has been revealed.
GSK split seems to be paying off as vaccines drive upgraded profit guidance January 31, 2024 "We are now planning for at least 12 major launches from 2025, with new Vaccines and Specialty Medicines for infectious diseases, HIV, respiratory and oncology," Emma Walmsley, chief executive at GSK said.
Life sciences firm hVIVO has record year as Canary Wharf site set for completion January 30, 2024 A leading firm testing infectious diseases, hVIVO, has reported a record year as it looks to start work on an £80m orderbook in 2024.
Another UK snub: Cambridge spin-out eyes New York IPO as unicorn status beckons January 29, 2024 Life sciences startup Nuclera has said it is eyeing up a public listing in New York in the next five years as it approaches unicorn status.
Tribunal upholds £84m CMA fine for firm that hiked drug prices August 8, 2023 The companies behind a drug whose price was hiked from £20 to £248 per pack in just eight years will be fined a combined £84 million after a tribunal upheld the competition watchdog’s decision. The Competition Appeal Tribunal on Tuesday had endorsed “all the main elements” of the Competition and Markets Authority’s decision, the CMA [...]
Pfizer’s revenue drops over 50 per cent as Covid-19 vaccine sales wither August 1, 2023 US drugmaker Pfizer today reported that revenue more than halved during the second quarter of the year as global demand for its Covid-19 vaccines plummeted. It reported disappointing revenues of $12.7bn (£9.9bn) in the three months April to June – down 54 per cent, or $15bn, from the second quarter last year. Pfizer blamed the [...]
GSK brings in zosta lot more cash as drugs giant’s turnover boosted by shingles vaccine and HIV medicines April 26, 2023 Drugs giant GSK has posted better-than-forecast revenues for the first quarter thanks to strong sales of its shingles vaccine and HIV medicines. The FTSE 100 group saw earnings fall 15 per cent on a constant currency basis to £2.1bn in the first quarter as revenues dropped eight per cent to £7bn after sales of its Covid-19 treatment [...]
GSK coughs up £1.6bn for Bellus as pharma giant boosts its patent medicine cabinet April 18, 2023 GSK plans to buy developer Bellus Health in an all-cash deal for £1.6bn as the drugmaker expands its bet on respiratory therapies.
Astrazeneca’s shares rise, as cancer drug uptake offsets fall in sales of pharma giant’s Covid-19 vaccine February 9, 2023 Astrazeneca has posted what it claimed were “strong” financial results for the full year 2022 as surging demand for cancer medicines offset a fall in Covid vaccine revenues. Shares in Astrazeneca jumped on the news as the firm said it expects another year of double-digit revenue growth in 2023. The British firm’s strong results came [...]
Warning of Lemsip, cough and cold medicine shortage as Brits battle winter flu January 4, 2023 Brits are struggling to get hold of cough and cold medicine as a nasty strain of flu sweeps the nation. It has been reported that there is a shortage of medicines such as throat lozenges, cough mixtures, Lemsip powders and pain killers. This comes after the UK Health and Security Agency issued a warning about [...]